{"id":"W1935342590","doi":"10.3310/hta19780","title":"A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN)","year":2015,"lang":"en","type":"article","venue":"Health Technology Assessment","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Cilag; Medical Research Council; Evidence Synthesis Programme; Allergan; Aston University; Pfizer; University of Pittsburgh; Queen's University; Health Technology Assessment Programme; Queen's University Belfast; National Institute for Health and Care Research","keywords":"Ranibizumab; Medicine; Bevacizumab; Macular degeneration; Diabetic retinopathy; Pegaptanib; Visual acuity; Ophthalmology; Regimen; Clinical trial; Randomized controlled trial; Cost effectiveness; Optometry; Surgery; Internal medicine; Diabetes mellitus; Chemotherapy","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004443574,0.0002918804,0.001627462,0.0004344053,0.0000908272,0.00001609627,0.0001340553,0.0002569449,0.000004201696],"category_scores_gemma":[0.001028547,0.0001911998,0.0002111585,0.0006303529,0.0001746441,0.00005631154,0.0001192123,0.0003913246,0.000007282411],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000895554,"about_ca_system_score_gemma":0.0007745606,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003541899,"about_ca_topic_score_gemma":0.00004442968,"domain_scores_codex":[0.9952365,0.002361781,0.0009945027,0.0005833408,0.0004284333,0.0003954646],"domain_scores_gemma":[0.9972947,0.001289008,0.0003537822,0.0004502593,0.0002289111,0.000383363],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7594795,0.005019561,0.1884621,0.0002692379,0.001929106,0.0002638848,0.0003748082,0.0002270781,0.0002630353,0.00192543,0.00002300012,0.04176327],"study_design_scores_gemma":[0.5635127,0.007825626,0.426312,0.0004400977,0.0002683892,0.00001599795,0.0001899848,0.0001807281,0.0002099678,0.0008952813,0.00004442938,0.000104763],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9663057,0.0003745732,0.001225308,0.002128289,0.0003329111,0.02940848,0.00001079791,0.00006201198,0.0001519605],"genre_scores_gemma":[0.9923577,0.0001101079,0.0005837698,0.0001907108,0.00002932162,0.006652941,0.00003381016,0.00002568249,0.00001600348],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2378499,"threshold_uncertainty_score":0.77969,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09060190211912343,"score_gpt":0.4689941303897434,"score_spread":0.37839222827062,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}